Coverage is mostly measured — 5 of 5 reports stay neutral.
Cronos Group Inc., a publicly traded cannabis company listed on Nasdaq, reported a modest share price increase of 1.09% to $2.78, trading below its 52‑week high of $3.43. The company is extending the timeline for its planned acquisition of Dutch firm CanAdelaar to accommodate regulatory approvals, while continuing to expand its medical cannabis operations in Germany and Israel and maintaining share buyback programs. Separately, Bloober Team’s horror‑survival video game "Cronos: The New Dawn" is currently available on multiple platforms, with a new DLC titled "Cronos: Lazarus" slated for release in fall 2026, featuring new combat mechanics and a storyline centered on the character known as the Warden.
Cronos Group’s stock rose 1.09% to $2.78, remaining 18.95% below its 52‑week high of $3.43.
The company has delayed the closing of its CanAdelaar acquisition to allow time for regulatory and licensing approvals.
International medical cannabis markets, particularly Germany and Israel, are highlighted as significant growth areas for Cronos Group.
Bloober Team’s "Cronos: The New Dawn" is available on PC, consoles, and Mac, with a new DLC "Cronos: Lazarus" expected in fall 2026.
The upcoming DLC promises enhanced combat and a narrative focusing on the Warden character.
Cronos Group shares are trading at $2.78, which is 18.95% below the 52‑week high of $3.43.
The timeline was extended to provide additional time for completing regulatory approvals and licensing requirements.
The DLC is scheduled for fall 2026 and will be available on PC (Steam, Epic Games Store, GOG), Nintendo Switch 2, Xbox Series X/S, and PlayStation 5.
Germany and Israel are identified as two of the company's most significant medical cannabis markets.
The DLC adds faster, more aggressive combat, including abilities like teleportation and new tactical decision‑making.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe